Related Experiment Video
Updated: Jun 11, 2026

11:20
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
[Simultaneous pars plana vitrectomy and glaucoma drainage device implant]
M J Suárez-Fernández1, E Gutiérrez-Díaz, A Julve San Martín
1Licenciados en Medicina, Servicio de Oftalmología, Hospital Universitario 12 de Octubre, Madrid, España. majesufe@hotmail.com
Archivos De La Sociedad Espanola De Oftalmologia
|July 13, 2010
Summary
Glaucoma drainage device implantation with pars plana vitrectomy effectively controlled intraocular pressure in secondary glaucoma. Visual acuity improved significantly in these cases, though outcomes varied in neovascular glaucoma.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Glaucoma Management
Background:
- Glaucoma drainage devices (GDDs) and pars plana vitrectomy (PPV) are established treatments for refractory glaucoma.
- Combining GDD implantation with PPV offers a potential surgical solution for complex glaucomatous conditions.
Purpose of the Study:
- To evaluate intraocular pressure (IOP) and visual acuity (VA) outcomes following simultaneous GDD implantation and PPV.
- To assess the safety and efficacy of this combined surgical approach in different types of glaucoma.
Main Methods:
- A retrospective review of 8 eyes (7 patients) undergoing combined GDD implantation and PPV.
- Patients included those with neovascular glaucoma (NVG) and secondary glaucoma (GS) from complicated cataract surgery or trauma.
- Two types of GDDs were used: Molteno implants for NVG and Ahmed valves for GS.
Main Results:
- Mean IOP decreased from 35.77 mmHg preoperatively to 11.5 mmHg postoperatively.
- The mean number of hypotensive medications decreased from 2.33 to 0.62.
- In GS, mean VA improved from <0.1 to 0.42 at 3 months. In NVG, visual outcomes were poor.
- Complications included tube obstruction, hemorrhage, ptisis bulbi, plate exposure, and bullous keratopathy.
Conclusions:
- Combined GDD implantation and PPV achieved good IOP control and improved VA in secondary glaucoma.
- While IOP was controlled in NVG, poor visual outcomes were attributed to underlying pathology and complications.
- This combined procedure demonstrates potential for managing complex glaucoma cases, with careful patient selection being crucial.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
